HRT After 60: Is It Safe to Start or Continue?

Medically reviewed by: Katelyn Schwartz, NP, Family Nurse Practitioner with Advanced Training in TRT, BHRT, and Menopause Care
Last reviewed: October 2026

Two women turn 62 in the same month. One has used hormone therapy since her early fifties and wonders if her birthday means she has to stop. The other never took it, and night sweats still wake her twice a week. Both are asking about HRT for women over 60, but the honest answers differ. Starting therapy at this age and continuing it are separate decisions, and the evidence treats them separately.

The topic made headlines in November 2025. That’s when the US Food and Drug Administration began removing most of the boxed warning from American hormone therapy labels. The Canadian Menopause Society welcomed the move but noted that it applies to US products only. The age guidance Canadian specialists follow hasn’t changed. If you’d like your own situation reviewed, our women’s health clinic in Vancouver can talk it through with you.

Is HRT for Women Over 60 Safe? The Short Answer

HRT for women over 60 is generally safer to continue than to start. Canadian guidance says systemic hormone therapy should not usually begin after 60 or more than 10 years past menopause, as stroke, clot and heart risks rise. Continuing can be reasonable with yearly review, and vaginal estrogen can be used long term.

Starting in your 60s: not usually advised, and only after a careful look at heart, stroke and clot risk.
Starting at 70 or older: current research points toward avoiding systemic therapy.
Continuing past 60 or 65: no automatic stop date, but the decision is reviewed every year.
Vaginal estrogen: a low dose that stays mostly local and is considered safe long term.
Route: estrogen absorbed through the skin carries less clot risk than a pill.

Why Age 60 Is the Number Everyone Mentions

Age 60 isn’t a switch that flips on your birthday. Instead, it stands in for something harder to measure: how long your blood vessels have gone without estrogen. Researchers behind the Women’s Health Initiative (WHI), a set of large US randomized trials, suggest estrogen may slow early artery changes. Later on, though, it may unsettle the more advanced plaque that builds over the years. So the same hormone can behave quite differently at 52 than at 67.

The 10-Year Window

That’s why guideline bodies frame the decision around two markers: being under 60, or being within 10 years of your final period. The Menopause Society, a US body formerly called the North American Menopause Society, publishes widely used guidance. Its 2022 position statement calls the balance favourable inside that window, for treating bothersome hot flashes or preventing bone loss. That assumes there are no reasons to avoid estrogen. For women who start later, it says the balance appears less favourable, because the absolute risks of heart disease, stroke, blood clots and dementia are greater.

If your periods stopped early, the 10-year mark can pass well before 60. Women in their forties face an earlier version of this question. Our guide to HRT for women in their 40s covers the signs that usually start it.

What the Trial Numbers Show by Decade

The WHI enrolled more than 27,000 women aged 50 to 79. A 2013 overview in JAMA then counted serious health events per 10,000 women per year. On combined estrogen and progestin, women in their fifties had 12 extra events, while women in their seventies had 38. On estrogen alone, women in their fifties had 19 fewer events, but women in their seventies had 51 extra.

A 2025 analysis of the same trials looked only at women with moderate or severe hot flashes, the group most likely to want treatment. In women in their fifties, a combined measure of heart attack, ischemic stroke and related artery events looked neutral. In their sixties, there was no clear signal of harm, but risk rose at 70 and older. So the authors, writing in JAMA Internal Medicine, advised caution about starting therapy in the 60s and avoiding it at 70 and older. These trials tested one oral estrogen, alone or with a synthetic progestin, at a single standard dose. Newer lower-dose and skin-based options weren’t part of them.

Starting HRT After 60: What Canadian Guidance Says

The Canadian Menopause Society’s pocket guide for health professionals is direct on this point. It says hormone therapy should not usually be started more than 10 years after menopause or after age 60. As support, it points to WHI data showing more coronary heart disease in women who began at 60 or older.

Still, “not usually” leaves some room. A few women in their early sixties have hot flashes that wreck their sleep, yet a low personal risk of heart disease and clots. For these women over 60, a licensed provider may weigh HRT as a low dose absorbed through the skin, after a careful look at heart, stroke and clot risk. The pocket guide adds that women at moderate cardiovascular risk who are offered therapy should preferentially use transdermal estrogen.

Newer evidence leans the same way. In a 2026 Menopause study of 83,147 women in Israel, starting at 65 or older was linked to higher rates of cancer and stroke. Its records didn’t show doses or routes, though. For more on timing, see our guide on whether you can start HRT after menopause.

Continuing HRT After 60 or 65

There’s No Automatic Stop Date

Women who began HRT in their fifties often hear that they must quit at 60 or 65. Canadian guidance doesn’t say that. The pocket guide states that stopping at 65 isn’t necessary. Likewise, Ontario Health’s October 2025 quality standard on menopause care sets no recommended duration or stop time. Instead, the pocket guide notes that guidelines advise revisiting the decision at least once a year. That review weighs your symptoms, bone health and any new risks against your reasons for starting.

The old “lowest dose for the shortest time” rule has softened. Even so, The Menopause Society asks that longer use rest on a clear reason, such as persistent hot flashes. Our article on how long you should take hormone replacement therapy covers that yearly review in more depth.

What Research on Women Over 65 Shows

One large look at continued use comes from the records of 10 million US Medicare beneficiaries, published in Menopause in 2024. Women who kept using estrogen alone past 65 (an option only after hysterectomy) had 19% lower all-cause mortality than women who never used it or stopped. By contrast, combined estrogen and progestogen was linked to a 10 to 19% higher breast cancer risk. That increase appeared smaller with low doses given through the skin or vaginally.

Keep in mind that these are observational findings. Women who stay on therapy into their late sixties may be healthier to begin with, so the study shows an association rather than proof. In other words, it’s reassuring for women who continue, but it isn’t a reason to start. The 2026 Israeli study also linked longer use to more health problems, so the evidence on continuing isn’t one-sided.

If You Decide to Stop

About half of women find their hot flashes return after stopping, however long it has been since menopause or how long they used therapy. Roughly half of those go back on it, according to the Canadian pocket guide. Neither tapering nor stopping at once has proven more successful. For what to expect afterwards, see what happens when you stop HRT.

HRT After 60 at a Glance

Here’s how current guidance generally sorts the most common HRT situations for women over 60. Since your own plan depends on your health history, treat this as a starting point.

Your situation	What guidance generally suggests
Starting systemic HRT at 60 to 69	Not usually advised; possible after a full heart, stroke and clot review
Starting systemic HRT at 70 or older	Generally avoided
Continuing therapy started earlier	Reasonable with a yearly review; no fixed stop age
Vaginal dryness or bladder symptoms	Low-dose vaginal estrogen, usable long term
Bone protection as the only goal	The same starting limits apply; discuss other bone treatments too

Patch or Pill? Why the Route Matters More After 60

Estrogen swallowed as a pill passes through the liver first, and the liver responds by making more of the proteins that help blood clot. Estrogen absorbed through the skin, as a patch or gel, skips that first pass. That difference is thought to explain why the two routes behave so differently.

The clearest data come from a 2019 BMJ study of UK health records. It compared 80,396 women who had a blood clot with 391,494 who hadn’t. Oral hormone therapy was linked to 58% higher odds of a clot in a vein, while transdermal estrogen showed no increase. For women over 60, clot and stroke risk both climb with age, which makes the HRT route matter more. That’s why the Canadian guide recommends a transdermal form for women at higher risk of clots or heart disease.

If you still have a uterus, estrogen also needs a progestogen partner to protect the uterine lining. According to the Canadian guide, transdermal estradiol with micronized progesterone carries the least clot and heart risk. To compare forms, see our overview of types of HRT for menopause and our page on bioidentical hormone replacement therapy.

Breast, Heart, Memory and Bones After 60

Breast Cancer

Here, the type of regimen makes a clear difference. In the WHI, estrogen alone after hysterectomy was linked to fewer breast cancers over long-term follow-up. Combined therapy, on the other hand, raised the risk, and part of that rise lasted for years after women stopped. Either way, routine breast screening continues while you’re on therapy.

Heart and Stroke

For heart attack risk, the age you start at matters. Stroke and clot risk, however, didn’t show the same advantage for younger women in the WHI. The Canadian guide also notes that migraine with aura is linked to double the stroke risk, so mention it if you have it. Our article on HRT and heart health goes further.

Memory

The WHI found more dementia among women over 65 on combined therapy. Similarly, the Canadian guide notes memory problems in women who began therapy after 65. Hormone therapy isn’t prescribed to protect memory, so brain health alone is never a reason to start in your sixties.

Bones

At standard doses, estrogen slows bone loss and lowers the rate of spine, hip and other fractures while you take it. Osteoporosis Canada’s December 2025 statement supports it as a bone option for women under 60 or within 10 years of menopause. Its focus is women who also want relief from substantial symptoms. It doesn’t address starting after 60, when the usual age limits still apply, so other bone treatments are worth discussing too.

Vaginal and Bladder Symptoms: Where the Age Rule Doesn’t Apply

Hot flashes often ease over time, though some women have them for years. Vaginal dryness, pain with sex, urgency and repeat bladder infections tend to do the opposite. The Canadian guide notes that these changes, called genitourinary syndrome of menopause, often worsen with age. Even so, many women in their sixties assume it’s simply part of getting older and never bring it up.

Low-dose vaginal estrogen comes as a cream, tablet, insert or ring. It works where it’s applied, with minimal absorption into the bloodstream. For that reason, the Canadian guide says the standard contraindications for systemic therapy don’t apply, and it can be used for life. Ontario Health also calls it safe and effective, so for women over 60 it’s the form of HRT with the fewest age limits. Even a past breast cancer doesn’t automatically rule it out, although that choice involves your cancer care team.

When Systemic Estrogen Isn’t an Option

The Canadian pocket guide lists the situations in which systemic estrogen should not be used:

vaginal bleeding that hasn’t been investigated
current, suspected or past breast cancer
known or suspected estrogen-dependent cancer, such as endometrial or ovarian cancer
coronary heart disease
a current or past blood clot in a vein
a current or past stroke
a known clotting disorder (thrombophilia)
active liver disease

Separately, any new vaginal bleeding after menopause needs prompt assessment, whether or not you use hormones.

Preparing for an HRT Conversation After 60

Questions Worth Bringing

How many years have passed since my last period?
What’s my current heart, stroke and clot risk?
Would estrogen through the skin suit me better than a pill?
Could vaginal estrogen alone cover my symptoms?
When will we review whether it’s still worth continuing?

How Care Works at Beyoung Health

Care begins with a confidential online health assessment. Next comes lab work through a free requisition, so your results are ready for your consultation. A licensed provider then reviews them with you by video and agrees a plan with you. If treatment is appropriate, the prescription goes to the pharmacy you choose, and follow-ups take place every three months. You can read more about women’s hormone care at Beyoung Health before you decide.

Your Next Step After 60

Think back to the two women at the start, both weighing HRT after 60. For the one already on therapy, the real question isn’t her birthday but whether her reasons still hold, and a yearly review answers that. For the one who never started, systemic hormones call for careful screening, and non-hormonal treatments for night sweats are worth discussing. Vaginal estrogen also stays open at any age if dryness or bladder symptoms appear. If you’d like a licensed provider to look at your history, you can book a consultation with our women’s health team.

HRT for Women Over 60: Common Questions

Q: Can a woman start HRT at 60?

It’s possible, but it isn’t usually advised. Canadian guidance says systemic hormone therapy should not usually begin after 60 or more than 10 years after menopause. Still, a licensed provider may consider a low dose through the skin for severe hot flashes when heart, stroke and clot risk are low.

Q: Do I have to stop HRT at 65?

No, you don’t. Women can continue HRT past 60 and 65, and the Canadian Menopause Society states that stopping at 65 isn’t necessary, and Ontario Health sets no stop time. Instead, the benefits and risks of continuing are reviewed at least once a year.

Q: Is vaginal estrogen safe after 60?

Low-dose vaginal estrogen stays mostly local, with minimal absorption into the bloodstream. As a result, Canadian guidance considers it safe and effective for dryness, painful sex and bladder symptoms. It can also be used for life.

Q: Are HRT patches safer than pills after 60?

For clots, observational evidence says yes. In a large UK study, oral hormone therapy was linked to 58% higher odds of a clot in a vein, while transdermal estrogen showed no increase. So Canadian guidance prefers patches or gels when clot or heart risk is higher.

Q: Will HRT protect my bones after 60?

Women over 60 who continue HRT keep estrogen’s bone benefit while they take it. However, Osteoporosis Canada supports hormone therapy for bone mainly before 60 or within 10 years of menopause. So if you’re starting after 60 for bone alone, other bone treatments belong in the conversation.

Q: What happens if I stop HRT after many years?

About half of women notice hot flashes come back, however long it has been since menopause or how long they used therapy. About half of those then restart. Because neither tapering nor stopping at once has proven better, it’s worth planning the approach with your provider.

This content is for informational purposes only and does not constitute medical advice. Speak with a licensed provider before starting, continuing or stopping any treatment.